# Hydroxychloroquine for the Treatment of Hidradenitis Suppurativa

> **NCT03275870** · PHASE1,PHASE2 · COMPLETED · sponsor: **Elena Gonzalez Brant, MD** · enrollment: 17 (actual)

## Conditions studied

- Hidradenitis Suppurativa
- Hidradenitis
- Acne Inversa
- Boils
- Follicular Occlusion Triad
- Follicular Occlusion Tetrad

## Interventions

- **DRUG:** Hydroxychloroquine

## Key facts

- **NCT ID:** NCT03275870
- **Lead sponsor:** Elena Gonzalez Brant, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-28
- **Primary completion:** 2019-06-30
- **Final completion:** 2019-06-30
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2020-04-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03275870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03275870, "Hydroxychloroquine for the Treatment of Hidradenitis Suppurativa". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03275870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*